Latest Breaking News On - Moderate dementia - Page 1 : comparemela.com

BioXcel Therapeutics Provides Update on Recent Developments for Late-Stage Clinical Programs and Expansion of IP Portfolio for IGALMI™ (dexmedetomidine) Sublingual Film

Meetings scheduled with FDA in October and November for TRANQUILITY and SERENITY III programs Company strengthens IGALMI™ market exclusivity through receipt of two Notices of Allowance .

Vimal mehtaScott stachowiakDavid schullBrennan doyleErik koppBioxceltherapeutics incWhile the companyExchange commissionDrug administrationCompany current report on formTrademark officeSecurities exchangeGlobenewswire incBioxcel therapeutics incXcel therapeuticsStage clinical programs

BioXcel Therapeutics (BTAI) Provides Update on Recent Developments for Late-Stage Clinical Programs and Expansion of IP Portfolio for IGALMI

BioXcel Therapeutics (BTAI) Provides Update on Recent Developments for Late-Stage Clinical Programs and Expansion of IP Portfolio for IGALMI
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vimal mehtaMediarusso partnersdavid schullBioxcel therapeuticserik koppRelationsbioxcel therapeuticsbrennan doyleCompany current report on formExchange commissionTrademark officeAboutbioxceltherapeutics incWhile the companyDrug administrationSecurities exchangeBioxcel therapeutics incBioxcel therapeuticsStage clinical programsModerate dementiaProbable alzheimer

Alpha Cognition Announces Fourth Quarter and Full Year 2021 Results and Company Update

Alpha Cognition Announces Fourth Quarter and Full Year 2021 Results and Company Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichael mcfaddenStefan eftychiouProgram developmentsVenture exchangeRegulation services providerAlpha cognition incAlpha cognitionChief executiveModerate dementiaCognition announced positive dataPre clinical studiesAmyotrophic lateral sclerosisPre clinical studyTraumatic brainBrain injury